Establishment of Neurospora crassa as a host for heterologous protein production using a human antibody fragment as a model product by Havlik, David et al.
Havlik et al. Microb Cell Fact  (2017) 16:128 
DOI 10.1186/s12934-017-0734-5
RESEARCH
Establishment of Neurospora crassa as a 
host for heterologous protein production using 
a human antibody fragment as a model product
David Havlik1,2,3, Ulrike Brandt2, Kathrin Bohle1 and André Fleißner2* 
Abstract 
Background: Filamentous fungi are commonly used as production hosts for bulk enzymes in biotechnological appli-
cations. Their robust and quick growth combined with their ability to secrete large amounts of protein directly into 
the culture medium makes fungi appealing organisms for the generation of novel production systems. The red bread 
mold Neurospora crassa has long been established as a model system in basic research. It can be very easily geneti-
cally manipulated and a wealth of molecular tools and mutants are available. In addition, N. crassa is very fast growing 
and non-toxic. All of these features point to a high but so far untapped potential of this fungus for biotechnological 
applications. In this study, we used genetic engineering and bioprocess development in a design-build-test-cycle pro-
cess to establish N. crassa as a production host for heterologous proteins.
Results: The human antibody fragment HT186-D11 was fused to a truncated version of the endogenous enzyme 
glucoamylase (GLA-1), which served as a carrier protein to achieve secretion into the culture medium. A modular 
expression cassette was constructed and tested under the control of different promoters. Protease activity was identi-
fied as a major limitation of the production strain, and the effects of different mutations causing protease deficiencies 
were compared. Furthermore, a parallel bioreactor system (1 L) was employed to develop and optimize a production 
process, including the comparison of different culture media and cultivation parameters. After successful optimiza-
tion of the production strain and the cultivation conditions an exemplary scale up to a 10 L stirred tank reactor was 
performed.
Conclusions: The data of this study indicate that N. crassa is suited for the production and secretion of heterologous 
proteins. Controlling expression by the optimized promoter Pccg1nr in a fourfold protease deletion strain resulted 
in the successful secretion of the heterologous product with estimated yields of 3 mg/L of the fusion protein. The 
fungus could easily be cultivated in bioreactors and a first scale-up was successful. The system holds therefore much 
potential, warranting further efforts in optimization.
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Background
Filamentous fungi play important roles in numerous bio-
technological applications. Examples from a plethora of 
industrial processes employing fungi include the produc-
tion of enzymes, organic acids or important secondary 
metabolites, such as antibiotics or immunosuppressive 
drugs [1, 2]. The main advantages of fungi as production 
organisms are their fast growth on a variety of inexpen-
sive media and an enormous metabolic wealth. In addi-
tion, filamentous fungi possess an unbeaten secretory 
capacity, reaching yields of secreted homologous proteins 
of up to 100  g/L [3]. Because of these many beneficial 
features, filamentous fungi have also advanced as expres-
sion hosts for heterologous proteins. A prominent exam-
ple is the production of bovine chymosin by Aspergillus 
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niger [4–6] yielding about 1 g/L of this heterologous pro-
tein. In contrast to prokaryotic microorganisms, fungi 
also provide eukaryotic posttranslational modifications, 
which are important for the stability and activity of many 
secreted proteins.
The filamentous fungus Neurospora crassa has long 
been established as a model organism in basic research 
covering a wide variety of scientific topics including 
cell polarity [7], circadian rhythms [8], cell fusion [9] 
or genome evolution [10]. However, despite a wealth of 
advantageous features, it has not yet advanced as a host 
for heterologous protein production in an industrial 
scale. The benefits of N. crassa include a plethora of avail-
able genetic and molecular tools, such as a gene knockout 
mutant collection [11], and exceptional fast and robust 
growth [12]. For example on synthetic growth media spe-
cific growth rates of 0.37 h−1 have been reported for N. 
crassa [13] compared to 0.07  h−1 in Trichoderma reesei 
[14] or 0.18 h−1 in Aspergillus niger [15]. N. crassa is non-
toxic, is traditionally used for food production in South 
East Asia, and is considered to be safe for food and tech-
nical applications [16]. In addition, due to its sexual life 
cycle [17], genetically different strains can be crossed, 
and mutations, deletions or expression cassettes can very 
easily be combined into one strain, allowing the develop-
ment of modular expression systems.
The general capability of N. crassa to produce and 
secrete heterologous proteins has already been demon-
strated. Previous studies reported the successful produc-
tion of a plant protein [18], bovine preprochymosin [19] 
and RNase A [20], as well as vaccines [21] with yields in 
the low µg/L up to mg/L range. However, in these stud-
ies, analysis was restricted to shake flask cultivations. 
Large scale approaches (airlift fermenters with volumes 
up to 6 L) have only been reported for the production of 
the homologous proteins tyrosinase [22] and acid phos-
phatase [23]. However, the most prevalent type of biore-
actors in biotechnology are stirred tank reactors (STR). 
A description of growth and development under these 
culture conditions is therefore a prerequisite for fur-
ther consideration of this fungus as a production host in 
industrial applications. To our knowledge, cultivations 
of N. crassa in STR for heterologous protein production 
have not been reported, yet. So far, cultivations in STR 
were carried out only in continuous mode of operation 
for studying the circadian clock [24] or gene expression 
under different environmental conditions [25].
The main advantage of filamentous fungi as expres-
sion systems is their ability to secrete the product into 
the growth medium. Secretion of heterologous pro-
teins is commonly achieved by their fusion to a highly 
secreted native protein in a carrier protein approach 
[26]. A frequently used carrier is glucoamylase, a multi-
domain enzyme cleaving starch into glucose monomers. 
Under inducing conditions, the glucoamylase GLA-1 of 
N. crassa is highly produced and secreted, making up to 
17% of all secreted proteins [27]. Glucoamylases con-
sist of an N-terminal catalytic domain and a C-terminal 
starch binding domain separated by an O-glycosylated 
linker [28]. This structure is especially well-suited as a 
carrier protein, since by replacing the starch binding 
domain with the protein of interest the native linker can 
be employed as a natural connection.
Despite their positive features, filamentous fungi also 
pose specific challenges in their use as microbial cell 
factories. The saprophytic fungal life style involves the 
secretion of catabolic enzymes into the growth environ-
ment, including proteases [29]. Once secreted, proteases 
cleave their substrates into peptides and amino acids, 
which are taken up by the cell as carbon, nitrogen and 
sulfur sources. Heterologous protein production there-
fore requires strict control of protease secretion in order 
to prevent product degradation. Common approaches 
of limiting protease activity include genetic modifica-
tion of the host strain and/or optimization of the culture 
processes. The former strategy involves for example the 
inactivation of protease encoding genes or the deletion of 
central regulators of protease production, such as tran-
scription factors [26, 30, 31]. In the latter approach, cul-
tivation conditions are identified which limit protease 
activity or production [32–34].
In addition, filamentous fungi adopt various morpholo-
gies in liquid cultures, ranging from dispersed hyphae to 
mycelial pellets or even robust mycelial mats, which accu-
mulate around submerged bioreactor parts [24] thereby 
hampering the production process. Morphogenesis and 
productivity are affected by a multitude of culture param-
eters, including pH value, temperature, aeration rate or 
media composition [35]. Since no general relationship 
between morphology and productivity exists, the opti-
mal growth form needs to be determined for every indi-
vidual production process. A detailed understanding of 
the environmental factors controlling morphogenesis is 
therefore a prerequisite for process optimization.
In this study, we set out to optimize N. crassa as a host 
for the production and secretion of heterologous pro-
teins, using the human antibody fragment HT186-D11 
[36] (an scFv, single chain fragment variable) as a model 
product. We identified secreted proteases as a major 
limitation for using N. crassa as a fungal cell factory. To 
meet this challenge and to improve yields, we combined 
genetic engineering and bioprocess development, thereby 
showing that only this combinatorial approach resulted 
in significant production optimization.
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Results
The aim of this study was to establish Neurospora crassa 
as a production host for heterologous proteins and to 
analyze and optimize its growth in stirred tank reactors. 
The work flow of this study is depicted in Fig.  1, rang-
ing from designing an expression system and generating 
production strains to cultivation in shake flasks (100 mL) 
and in a parallel bioreactor system (1  L) to finally con-
ducting a first scale-up. Since so far neither robust 
Neurospora-based expression systems nor protocols for 
cultivation in stirred tank reactors are available, we chose 
a “design-build-test-cycle” approach, in which the expres-
sion cassettes, the host strain, and the growth conditions 
are optimized in an iterative manner.
Construction of an expression system
In a first step, a modular expression vector was designed, 
in which every building block can easily be replaced 
(Fig. 1). It contains an ht186-d11 human antibody cDNA, 
which was codon optimized for N. crassa. To enable 
secretion of the heterologous protein, a carrier protein 
approach was chosen, employing a truncated version of 
the highly secreted glucoamylase GLA-1 of N. crassa as 
the carrier. GLA-1 homologs are commonly employed 
to promote secretion of heterologous proteins in fila-
mentous fungi [18, 37, 38]. In the expression vector, the 
5′-end of the antibody encoding sequence was fused to 
the truncated gla-1 sequence (glat), encoding the cata-
lytic subunit of GLA-1 and the native linker sequence. 
The starch-binding domain encoding sequence of gla-1 
was therefore replaced by the antibody’s ORF. The 3′-end 
of the antibody gene was fused to a 13×myc-tag [39], for 
detection by Western blot analysis. To identify a suitable 
promoter for heterologous expression, we tested three 
candidate regulatory sequences. First, the gla-1 pro-
moter, which is the starch or maltose inducible native 
promoter of the GLA-1 carrier encoding gene [40]. Sec-
ond, the light inducible vvd promoter, which allows tun-
able gene expression [41], and third, the ccg-1 promoter 
[42, 43], which is routinely used for overexpression in 
basic research. The three promoters were individually 
cloned into the expression construct, yielding the plas-
mids pDH011 (Pgla-1), pDH014 (Pvvd) and pDH016 
(Pccg-1). All constructs were based on plasmid pMF276, 
which allows targeted, single-copy integration into the 
his-3 locus of N. crassa [39].
In choosing a recipient strain for these expression 
constructs, we considered wild-type protease activity 
by secreted proteases as one major challenge. Protease 
activity in the culture supernatant, which can lead to 
complete degradation of the secreted heterologous prod-
uct, is a common, major hurdle in establishing filamen-
tous fungi as expression hosts. To test, if production of 
HT186-D11 would be affected by secreted proteases, the 
N. crassa wild-type strain FGSC #2489 was cultivated in 
shaking culture for 96 h. Every 12 h, samples of the cul-
ture fluid were taken and added to HT186-D11, which 
had been produced in E. coli. After 24  h of incubation, 
all samples exhibited severe degradation of the antibody 
fragment, indicating the presence of secreted proteases, 
which rendered the wild-type strain unsuited for anti-
body production (Fig. 2a). An earlier study reported that 
Fig. 1 Schematic overview of the production process development. The modular expression cassette comprises a sequence encoding a truncated 
version of the GLA-1 (glat), the product gene ht186-d11, and positions for various promoters and tags. Initial tests for optimization of the expression 
system were conducted in shake flasks cultures. For the subsequent process optimization a parallel bioreactor system was employed. Finally, a first 
scale-up approach in a 10 L stirred tank reactor was carried out. All optimizations were based on a design-build-test-cycle approach
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deletion of the vib-1 gene, encoding a transcriptional 
regulator, results in a strong decrease of protease activity 
despite starving conditions in N.  crassa [44]. We there-
fore tested Δvib-1 (strain FGSC #11309) in the described 
manner. HT186-D11 was significantly more stable in the 
presence of Δvib-1 supernatants, confirming its reduced 
protease activity (Fig. 2a). We therefore crossed the vib-1 
knockout into the his-3 strain (FGSC #9716) to construct 
the recipient strain DHN-077. Subsequent transforma-
tion with pDH011, pDHP014 and pDH016 resulted in the 
three production strains DHN-117, DHN-118 and DHN-
120, respectively.
In the next step, the performance of the three pro-
ducer strains was analyzed in shake flask cultures. Since 
the activity of two of the employed promoters is known 
to be influenced by the carbon source, growth and pro-
ductivity was compared on minimal medium (MM) 
containing either sucrose, glucose, acetate or maltose 
as the sole carbon source. Sucrose is the carbon source 
of the commonly used Vogel’s MM, while glucose was 
employed in the initial study describing the use of the 
vvd promoter for tunable expression. Both sugars have 
however been shown to partially repress Pccg-1 activ-
ity, while this inhibition is absent on acetate. Maltose 
on the other hand is a natural inducer of gla-1. Cultures 
were incubated at 15 °C, to promote more precise pro-
tein folding at this lower temperature. After 7  days of 
cultivation the mycelia were harvested and biomass and 
supernatant were analyzed for the presence of HT186-
D11 by Western blot analysis. While in all biomass-
associated samples antibodies were detected, only the 
supernatant of DHN-120 grown on maltose unambigu-
ously contained the antibodies (Additional file  1: Fig-
ure S1). While these findings indicate that N. crassa is 
in general able to produce and secrete HT186-D11, the 
employed production system and growth conditions 
did not deliver satisfactory results and required further 
optimization.
Our data indicated that the major amount of pro-
duced antibody was biomass associated. However, this 
analysis could not distinguish if the heterologous protein 
was not secreted or if it remained linked to the cell wall 
after secretion. Glucoamylases are commonly associated 
with the cell wall [28], which could also be the case for 
our carrier protein construct. Earlier studies in N. crassa 
identified the exo-1 mutant, which significantly hyperse-
cretes GLA-1 into the culture medium, probably because 
of reduced cell wall association [45, 46]. When we com-
pared general secretion of the wild-type and the exo-1 
mutant, this hypersecretion phenotype was confirmed 
(Fig. 2b). We therefore constructed a second set of pro-
duction strains by introducing the exo-1 mutation into 
our original expression isolates. In addition, the vvd gene 
was deleted, since its gene product has been reported 
to inhibit activity of the vvd promoter [41], resulting in 
strains DHN-177 (Pgla-1), DHN-201 (Pvvd), and DHN-
172 (Pccg-1). The strains were cultivated in modified 
Vogel’s minimal medium with maltose as the sole carbon 
source, since in the initial experiment cultivation on this 
sugar delivered the best results. Since the cultivation at 
the low temperature of 15  °C had no positive outcome, 
we cultivated in parallel at 25 °C, which promotes faster 
and more robust growth of the fungus. Surprisingly, 
presence of the exo-1 mutation did not improve product 
levels in the supernatant and only degradation products 
were detected with DHN-172 (no signals with DHN-177 
and DHN-201) (Additional file  1: Figure S2). The exo-1 
mutants formed, however, a more homogeneous biomass 
with less clumps, thereby promoting reproducibility due 
to easier and more consistent sampling (data not shown). 
We therefore decided to maintain the exo-1 mutation in 
the next generation production strains.
Fig. 2 Potential improvement of the production host by deletion of 
vib-1 and introduction of exo-1. Deletion of vib-1 results in a signifi-
cant decrease in protease activity (a), and the exo-1 mutation causes 
hypersecretion of a set of proteins (b). To determine protease activity 
in the culture supernatant (a), the wild-type (WT) and the vib-1 dele-
tion strain (∆vib-1) were cultivated in liquid minimal medium with 
maltose at 30 °C. Samples of the supernatant were harvested at the 
indicated time points and incubated for 24 h with 1 µg of HT186-D11. 
The samples were then analyzed by SDS-PAGE. Presence of the intact 
antibody fragment is indicated by a band at 30 kD. If protease activity 
is present in the tested supernatant, smaller degradation products 
appear or the band fully disappears. To test the hypersecretion of exo-
1 strains (b), wild-type (WT) and exo-1 were cultivated for 3 days in 
liquid minimal medium with maltose at 30 °C. Proteins in the super-
natant were precipitated, concentrated (factor 30) and separated with 
SDS-PAGE. I–III indicates three independent replica. The main band 
present between 60 and 70 kD represents GLA-1
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We hypothesized that production and secretion of 
the native glucoamylase might inhibit the production of 
the carrier-antibody construct in a competitive manner. 
We therefore introduced a Δgla-1 mutation into the last 
tested generation of production strains, resulting in the 
isolates DHN-178 (Pgla-1), DHN-182 (Pvvd) and DHN-
176 (Pccg-1). These strains grew 5–7 times slower than 
the gla-1+ isolates when being cultivated in modified 
Vogel’s minimal medium with maltose, and at least 20% 
of the sugar was still present at time points when gla-1+ 
strains had already depleted the carbon source (data not 
shown). Full size fusion protein as well as degradation 
products were detected for the isolates carrying the Pvvd 
and Pccg-1 promoters (Additional file 1: Figure S3). The 
presence of degradation products indicated that protease 
activity had reoccurred in these cultures, which was cor-
roborated by protease activity assays using the E.  coli-
produced antibody as a substrate (data not shown). 
Full size fusion protein could probably only be detected 
because the Δgla-1 strains had not started to secrete pro-
teases when harvested due to their slower growth. The 
hypothesized beneficial effects on secretion of the fusion 
protein were not observed.
Based on these findings, we concluded that the deletion 
of gla-1 had rather detrimental effects and that optimized 
production strains therefore carry the Δvib-1 and exo-1 
mutation in a gla-1+ background and, in case of employ-
ing the vvd promoter, a vvd gene deletion.
Characterization and optimization of the culture 
conditions
After establishing the optimized expression systems 
and production strains, we set out to test the influ-
ence of various cultivation parameters. All of the above 
described experiments were conducted in shaking flask 
cultures. Since many cultivation parameters, such as 
dissolved oxygen levels and pH value, can, however, not 
be controlled in flasks, we turned to a parallel bioreac-
tor system with a working volume of 800 mL for further 
experiments.
In a first cultivation, strain DHN-201 (Pvvd) was grown 
under constant illumination to induce protein produc-
tion. The dissolved oxygen level was stably maintained at 
20% and the pH value was restricted to a minimum of 4.5, 
since an earlier study reported maximum hyphal growth 
on agar at pH 4.5 [47], meaning that it was allowed to rise 
above but not to fall below 4.5. Since cultivations at low 
temperatures did not show any advantages, we returned 
to cultivations at 30  °C which is an established cultiva-
tion temperature in basic N. crassa research [48–50]. To 
follow and describe growth of these cultures the param-
eters dissolved oxygen, stirrer speed, produced  CO2, pH, 
and mycelial dry weight were monitored (Fig. 3a). Under 
these conditions, N.  crassa grew in form of dispersed 
hyphae and no major hyphal aggregates or pellets were 
detected. Cultivation of filamentous fungi in stirred tank 
reactors is frequently hampered by adherence of the bio-
mass at and around the stirring elements. However, the 
developing biomass did not negatively interfere with the 
stirring elements of the bioreactor, demonstrating that N. 
crassa is suited for the cultivation in stirred tank reactors 
(Fig. 3b).
Samples were taken for up to 43 h of cultivation. Pro-
teins were precipitated from the culture filtrate and ana-
lyzed by Western blot analysis (Fig.  3c). Only very faint 
signals for the heterologous protein were detected at time 
points 19 and 23 h at approximately 105 kD. The protease 
assay revealed significant protease activity for all time 
points after 4 h, indicating that the Δvib-1 mutation does 
not sufficiently suppress the expression of proteases dur-
ing cultivation in the stirred tank reactor.
To address this newly arisen protease activity, we 
turned to optimizing of the culture conditions, focusing 
first on the amount of nitrogen in the growth medium. 
To test the influence of the nitrogen source, we substi-
tuted the beforehand used Vogel’s minimal medium by 
Bird medium [51]. Bird medium contains only one type 
of nitrogen source allowing the systematic analysis of 
changes in this nutrient concentration. When cultivated 
on regular Bird medium (containing 25  mM  NH4+), 
growth of the production strain DHN-201 ceased after 
24 h. Interestingly, at this time point the nitrogen source 
was fully depleted, while only about 50% of the sugar was 
consumed, suggesting that Bird medium is N-limited. 
We therefore increased the amount of nitrogen in the 
medium. As a result, increased  NH4+ concentrations 
extended the growth period (Additional file  1: Figure 
S4A–C). However, the desired effect of suppressing the 
protease activity was not observed (Additional file 1: Fig-
ure S4D). For the subsequent experiments, the nitrogen 
source concentration was, nevertheless, increased from 
25 mM ammonium to 65 mM ammonium to prevent fur-
ther nitrogen limitations. At the same time we changed 
the nitrogen source from ammonium chloride to ammo-
nium sulfate, to also increase the sulfur concentration, 
which could also represent a critical factor affecting pro-
tease activity.
Protease activity commonly depends on the pH value 
of the surrounding medium [52–55]. We therefore 
hypothesized that this product degrading activity could 
be controlled by pH adjustments. At first, preliminary 
cultivations with pH values between 4.5 and 9.0 were 
conducted and the protease activity was determined 
(data not shown). The three pH values 6.5, 6.8 and 7.2, 
which still allowed proper growth of the fungus and that 
were expected to lead to the lowest protease activity, 
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were tested. The protease activity was reduced with 
decreasing pH values, however, a complete repression of 
the destructive activity was not achieved (Fig. 4). At pH 
6.5, protease activity was significantly delayed compared 
to the cultures with a higher pH. In addition, the maxi-
mum specific protease activity was also reduced at the 
lowest pH. In summary, these experiments did not fully 
solve the protease activity issue, however, they revealed 
optimized ammonium concentrations (65  mM) and an 
optimal culture pH of 6.5.
To evaluate the impact of the process optimization on 
the performance of the various production strains car-
rying the different expression cassettes, cultivations 
under optimized conditions (constant pH 6.5, 65  mM 
ammonium) were conducted. Since so far no cultiva-
tion condition supported the production of the heter-
ologous fusion protein when the glucoamylase promoter 
was employed for expressional control, strain DHN-178 
was excluded. Instead, Pccg1nr was introduced as a new 
promoter in addition to Pvvd and Pccg-1. This newly 
employed promoter is a variant of Pccg-1. Although 
Pccg-1 is routinely used for overexpressions in N. crassa, 
its regulation is complex and it is partially repressed by 
glucose [42]. An earlier study reported that the dele-
tion of two binding sites of repressor elements in the 
promoter sequence results in a complete loss of this 
glucose repression [56]. The production strains DHN-
201 (Pvvd), DHN-172 (Pccg-1), and DHN-250 (Pccg1nr) 
were cultivated in the parallel bioreactor system and 
production of the heterologous antibody fragment was 
analyzed (Fig. 5). The choice of promoter did not signifi-
cantly impact the growth behavior or the protease activ-
ity (Fig. 5a, b). Western blot analysis revealed production 
of the heterologous protein in all three cultivations. Use 
of the Pccg1nr promoter resulted in highest yields, while 
the Pvvd promoter strain produced the least (Fig.  5c). 
Despite the potential repression of the Pccg-1 promoter 
by glucose, which is released during metabolism on malt-
ose, product levels were higher with Pccg-1 than with 
Pvvd promoter. In all three cultures, increasing amounts 
Fig. 3 Cultivation of N. crassa in small scale stirred tank reactors. a Growth characteristics of the fungus monitored by online and offline data. Strain 
DHN-201 (Pvvd-glat-ht186-13×myc, exo-1, Δvib-1, Δvvd) was cultivated in a controlled 1 L bioreactor system in minimal Vogel’s medium with maltose 
as the carbon source at 30 °C. The dissolved oxygen level was maintained at 20% by controlling the stirrer speed. The pH value was maintained 
above 4.5 by the controlled addition of ammonia. b Macroscopical phenotype after 69 h of cultivation. Left culture in the bioreactor; Right Stirrer 
after cultivation. c Analysis of heterologous fusion protein production. Proteins in the supernatant were concentrated and separated with SDS-PAGE 
(S). After the Western blot transfer (WB), the tag was detected and signals were developed by electrochemiluminescence (development time of 
15 min). The arrows indicate the expected molecular mass of the fusion protein. The protease assay (P) was performed as described above
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Fig. 4 The pH value of the culture medium influences growth and the extracellular protease activity. a Growth characteristics and b protease 
activity in cultivations with different pH values. The production strain DHN-201 (Pvvd-glat-ht186-13×myc, exo-1, ∆vib-1, ∆vvd) was cultivated in a 
controlled 1 L bioreactor system in minimal Bird medium with maltose as the sole carbon source at 30 °C. The pH value was controlled at indicated 
levels by addition of sodium hydroxide throughout cultivation. For the protease activity, the before mentioned protease assay was performed, band 
intensities were determined via image processing software and ratios calculated in respect to an undigested HT186-D11. Subsequently, those val-
ues were divided by the cell dry mass. Due to different growth rates, the culture time had to be normalized. Therefore, the amount of produced  CO2 
at the maximal  XCO2 value was calculated and defined as 100%  (CO2, max). Hence, protease activity values at a certain abscissa value are comparable
Fig. 5 Process optimization results in the production of significant amounts of heterologous protein. a Growth characteristics  (XCO2: graph; dry 
mass: data points) and b protease activity of production strains with different promoters under optimized process conditions. Cultivation was con-
ducted in a controlled 1 L bioreactor system in minimal Bird medium with maltose as the sole carbon source at 30 °C. The pH value was controlled 
at pH 6.5 by the addition of sodium hydroxide throughout cultivation. Protease activity was determined as stated above. The employed strains were 
Pvvd (DHN-201: Pvvd-glat-ht186-13×myc, exo-1, ∆vib-1, ∆vvd), Pccg-1 (DHN-172: Pccg-1-glat-ht186-13×myc, exo-1, ∆vib-1, ∆vvd) and Pccg1nr (DHN-250: 
Pccg1nr-glat-ht186-13×myc, exo-1, ∆vib-1, ∆vvd). c Production of the heterologous fusion protein. Concentrated proteins from the supernatant were 
separated via SDS-PAGE (S) and the product was detected after Western blot transfer (WB). The signal was developed with electrochemilumines-
cence (development time of 1 s)
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of degradation products were detected in the course of 
the cultivation leading to a complete loss of all signals 
after 42  h. Although the protease activity was signifi-
cantly decreased in the optimized process, the remaining 
activity still caused complete loss of full size fusion pro-
tein indicating that even the combination of the ∆vib-1 
genetic background with the optimized cultivation con-
ditions is still not sufficient for a satisfactory production 
process.
Identification of critical protease genes
Besides mutating a protease regulator gene, such as 
∆vib-1, deletion of particular protease genes constitutes 
another strategy for generating protease deficient iso-
lates [31]. For N. crassa a gene knockout mutant library 
is available [11], which allowed the analysis of numerous 
protease gene deletion mutants. Combining several indi-
vidual mutations into one production strain is also a sim-
ple task, since N. crassa is easily sexually crossed under 
laboratory conditions. We therefore analyzed 26 isolates 
carrying knockout mutations in predicted protease genes 
for a reduced ability to degrade the HT186-D11 frag-
ment. Eight of these strains exhibited different degrees 
of significantly reduced protease activity. To compare 
the deficiencies of these strains, a score was introduced 
(Additional file  1: Table S1; Figure S5). The mutations 
of the four highest scoring strains (∆spr-7, ∆apr-9, 
∆NCU00263 and ∆apr-3, abbreviated as 4×∆prot) were 
combined into one single production strain. Because 
∆apr-3 and ∆apr-13 mutations had the same score, ∆apr-
3 was randomly chosen. In addition, the exo-1 muta-
tion was again introduced into the quadruple knockout 
strain. As an expression cassette the construct carrying 
the Pccg1nr promoter was chosen, which had shown the 
best performance in the above-described experiments. 
Since the last cultivations had resulted in secreted heter-
ologous protein, we now also considered purification of 
this product. Therefore, the 13×myc-tag, which we had 
used for immunochemical detection of the antibody frag-
ment, was replaced by a  his10-tag which allows for a more 
economic method of protein purification. This resulted 
in a decrease in molecular mass of the fusion protein 
from 105 to 85 kD. The obtained strain was designated 
as DHN-270. To compare the effect of the four protease 
gene deletions to the ∆vib-1 deletion, the expression con-
struct was also introduced into a Δvib-1, exo-1 isolate, 
resulting in strain DHN-252.
Both strains were cultivated in the parallel bioreactor 
system in optimized Bird medium with maltose as the 
sole carbon source. In addition, both isolates were also 
grown on a complex medium consisting of yeast extract, 
tryptone, malt extract and maltose, since we hypoth-
esized that its constituents, such as peptides and amino 
acids, could result in a further decrease in protease activ-
ity. Since the growth rates of the isolates slightly differed, 
growth phases were determined by the percentage of the 
estimated maximal  XCO2 value (e.g. 80% of  XCO2, max) 
observed in preliminary cultivations for better compara-
bility. At comparable stages protease activity and prod-
uct formation were determined (Fig. 6). As a result, the 
4×∆prot production strain developed more robustly, 
while growth of the ∆vib-1 strain was characterized by 
short interruptions that were independent of the growth 
medium. This growth behavior was not representative 
for all cultivations but was observed several times in 
independent experiments (data not shown). Both strains 
grew faster and reached higher  XCO2 values in the com-
plex medium (Fig.  6a). In optimized Bird medium, the 
4×∆prot strain reached significantly higher product lev-
els than the reference strain (protein band at 85 kD). Its 
protease activity was significantly reduced compared to 
the Δvib-1 strain, indicating that the strategy of deleting 
the protease genes was successful (Fig. 6b, c). Despite the 
different growth behaviors, both strains produced simi-
lar amounts of fusion protein in complex medium, which 
were higher than in Bird medium. This increased produc-
tivity correlated with approximately 40% higher biomass 
levels (data not shown). For both strains, no significant 
protease activity was detected in complex medium, 
supporting our hypothesis on the medium’s influence. 
Because of the more robust growth and the good per-
formance in defined and complex medium, the 4×∆prot 
production strain (DHN-270) was chosen for further 
experiments.
First scale‑up approaches
After the optimization of the expression cassette, the 
genetic background of the recipient strain and the culture 
conditions resulted in robust production of the HT186-
D11 antibody, a first scale-up attempt was conducted.
Strain DHN-270 was grown in complex medium in a 
10 L stainless steel stirred tank reactor. Three independ-
ent cultivations were conducted to demonstrate repro-
ducibility. The growth behavior was monitored and the 
production was analyzed by the established methods 
(Fig. 7). Showing only slight variations, all three cultures 
grew in a fashion comparable to the development in the 
parallel bioreactor system. Exhaust gas values as well as 
dissolved oxygen levels and stirrer speed were similar, 
indicating that the chosen culture conditions allow for 
robust and reproducible growth of N. crassa. No protease 
activity was observed and the full size product without 
any degradation products was detected (Fig. 7b). Finally, 
the product concentration in the culture supernatant was 
estimated based on the immunostain results by compar-
ing the signal strength of HT186-D11 produced in E. coli 
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and the signal of the fusion protein after 21 h of cultiva-
tion. A total of 3  mg/L of heterologous fusion protein 
was detected, indicating that the developed expression 
system allows the production of significant amounts of 
heterologous protein, therefore providing the basis for 
further optimizations and novel applications.
Discussion
The results of this study demonstrate that Neurospora 
crassa is generally suited as a host for heterologous pro-
tein production. After the expression system was geneti-
cally optimized and the culture conditions were adjusted, 
a significant amount of heterologous fusion protein was 
produced. Our study identified secreted proteases as a 
major roadblock, which we addressed by two different 
strategies. While deletion of the transcriptional regula-
tor VIB-1 appeared as an efficient method for achieving 
protease deficiency [44], cultivation in a small laboratory 
bioreactor demonstrated that the ∆vib-1 mutant neither 
has a sufficiently decreased protease activity nor grows 
in the robust manner required by industrial production 
processes. In contrast, the more time consuming sec-
ond strategy of combining several protease gene dele-
tion mutations resulted in significantly reduced protease 
activity, while still enabling robust and reproducible 
growth.
Comparison of the production strains from the two dif-
ferent protease deficiency strategies in defined Bird and 
complex medium suggested that protease regulation in 
∆vib-1 strains is more complex than expected. It has long 
been demonstrated that protease activation is linked to 
nutrient limitation, including nitrogen, sulphur or carbon 
starvation [52, 57, 58]. Environmental proteins provide 
rich sources of these elements and protease secretion 
is therefore a common part of the fungal starvation 
response [59]. Consistent with this notion, the addition 
of different amino acids represses the secretion of certain 
proteases [60]. This might explain why ∆vib-1 production 
strains did not show any protease activity when being 
cultivated in complex medium, which contains a mixture 
Fig. 6 Fourfold protease deletion results in higher protein yields due to lower protease activity. a Exhaust gas composition as a representative value 
for the growth characteristics. Cultivation was conducted in a parallel bioreactor system in minimal Bird medium (BM) and complex medium (CM). 
The employed strains were ∆vib-1 (DHN-252: Pccg1nr-glat-ht186-10×his, exo-1, ∆vib-1, ∆vvd) and 4×∆prot (DHN-270: Pccg1nr-glat-ht186-10xhis, exo-1, 
∆spr-7, ∆apr-9, ∆apr-3, ∆NCU00263). b Analysis of heterologous protein production. Proteins from the supernatant (not concentrated) were separated 
via SDS-PAGE (S) and the product was detected after Western blot transfer (WB). The signal was visualized directly on the membrane with an NBT/
BCIP system. The protease assay (P) was performed as mentioned above. c Yield quantification via Western blot analysis. Band intensities in b were 
quantified via image processing software and ratios calculated in relation to HT186-D11 (HT, 25 ng) produced in E. coli. As a negative control, strains 
with an exo-1, Δvib-1 background (K1, strain DHN-141) and exo-1 (K2, strain FGSC #2256) were used (no production strains)
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of amino acids. In addition, the secreted proteases might 
use peptides present in complex media as substrates, 
resulting in an apparent elimination of protease activity 
in the culture supernatant.
Although the use of complex medium solved the pro-
tease activity problem encountered when using the ∆vib-
1 production strain, this mutation proved unsuited for 
the construction of expression hosts. In our cultivations, 
∆vib-1 strains grew in both complex and defined media 
in an unpredictable manner, indicated for example by 
unexplained interruptions during exponential growth. It 
has been reported that VIB-1 is also involved in carbon 
catabolite repression and in glucose signaling [61]. The 
deletion of this gene might therefore result in undesir-
able and difficult to predict metabolic changes during the 
production process. Taken together these observations 
prompted us to employ instead the quadruple protease 
deletion strain for a scale-up.
A key step in optimizing the production process was 
the adjustment of the media composition, particularly 
the nitrogen concentration. The original Bird medium 
possesses a C/N ratio of 24, resulting in a nitrogen limita-
tion [51]. Lowering this ratio to 11 provided the produc-
tion strain with nitrogen amounts sufficient for extended 
growth and protein production. When comparing the 
production media of different filamentous fungi such as 
Aspergillus spp. and Trichoderma reesei C/N ratios of 
2–6 are described [15, 34, 62, 63], demonstrating further 
potential for optimization.
Another crucial aspect of our process development 
was the pH optimization. At pH 6.5 protease activity was 
mostly suppressed. N. crassa secretes a variety of differ-
ent proteases [64], which possess different pH optima, 
resulting in their classification as acid [54, 55], neutral 
[52] and alkaline proteases [53]. Our data indicate that at 
pH 6.5 most proteases are inactive, suggesting that most 
of the N. crassa proteases secreted under our cultivation 
conditions are acid proteases.
As part of the genetic optimization strategy, we included 
the exo-1 mutation into the production strains. The exo-1 
Fig. 7 Process scale up to 10 L shows comparable growth and production characteristics. a Growth characteristics of three cultivations in 10 L 
stirred tank reactors (I–III) in complex medium with maltose as carbon source at 30 °C. The employed strain was DHN-270 (Pccg1nr-glat-ht186-10xhis, 
exo-1, ∆spr-7, ∆apr-9, ∆apr-3, ∆NCU00263). The dissolved oxygen level and pH value (pH 6.5) were controlled as in the small scale experiments. b 
Production analysis of cultivation II. Proteins from the supernatant were separated via SDS-PAGE (S) and the product was detected after Western 
blot transfer (WB). As a negative control (K), a comparable production strain missing the  his10-tag was used (DHN-281, Pccg1nr-glat-ht186-13xmyc, 
exo-1, ∆spr-7, ∆apr-9, ∆apr-3, ∆NCU00263). The signal was visualized directly on the membrane with an NBT/BCIP system. The protease assay (P) was 
performed as mentioned above. As a positive control, HT186-D11 (HT, 10 μg/mL) was used
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mutant was described as a hypersecreting strain overpro-
ducing various exoenzymes [45, 46], especially the glucoa-
mylase GLA-1, which we employed as a carrier protein. 
However, the desired effect of yield improvement was not 
observed after incorporation of exo-1 into the production 
strains. The mechanism resulting in hypersecretion in 
exo-1 is so far not understood. It is possible that the exo-1 
effect includes a hyperactivation of the glucoamylase pro-
moter, which in our study was replaced by different pro-
moters. In addition, hypersecretion might require carbon 
starvation [45, 46], which did not occur in our cultiva-
tions. While the introduction of exo-1 into the production 
strains did not deliver the desired effect, it resulted, how-
ever, in more homogeneous mycelial growth in the biore-
actor and therefore contributed to reproducible growth 
and a facilitation of sampling.
Compared to previous reports of heterologous protein 
production in N. crassa, our production process resulted 
in significantly higher amounts of heterologous protein. 
Considering only the heterologous protein (in our case 
the scFv of ca. 31  kD) without the carrier, a calculated 
product concentration of ca. 0.9  mg/L was achieved, 
while earlier studies reported the production of 10 µg/L 
of zeamatin [18] or 356 µg/L of RNase A [20]. Only the 
production of preprochymosin led to a similar concen-
tration of 0.9–1.2  mg/L [19]. Compared to other long-
established fungal expression systems, these numbers 
are still low. In A. niger [63] and T. reesei [65] yields of up 
to 100 and 150 mg/L were reached for similar proteins, 
indicating further optimization potential for N. crassa.
In other eukaryotic production hosts, such as the yeast 
Pichia pastoris, higher yields between 150 and 300 mg/L 
were achieved for antibody fragments [66, 67]. The cur-
rent standard eukaryotic system for the production of 
pharmaceutical proteins is Chinese hamster ovary cells 
(CHO). These are usually employed for more complex 
proteins such as full-length antibodies yielding up to 
12 g/L in industrial settings [68].
Although N.  crassa does not achieve such high yields 
yet, further optimization might be worthwhile due to a 
number of advantageous features over the common pro-
duction systems. Due to its long and successful history 
as a eukaryotic model organism, a plethora of genetic 
resources and methods are available including the fully 
sequenced and annotated genome and [64, 69] and a 
gene knockout mutant library [11]. In addition, targeted 
integration allows the incorporation of DNA fragments 
into virtually every genomic locus. Strain construction 
is therefore reproducible and transcriptionally highly 
active loci can be targeted for the insertion of expression 
cassettes. Other potential advantages over CHO cells 
include the quick development of production host lines 
by sexual crossing and extremely fast growth, resulting in 
processing times of a few days rather than several weeks.
Our study also demonstrates that N. crassa is suited for 
the cultivation in a stirred tank reactor. Under the cho-
sen conditions the fungus showed free mycelial growth 
instead of pellet formation, which is the common growth 
form of many filamentous fungi [70]. Due to the exo-1 
mutation, long filaments did not form in the bioreactor 
resulting in a homogenous culture broth with a relatively 
low viscosity (data not shown). The process was eas-
ily scaled up from shake flask with a volume of 100 mL 
medium to 10 L bioreactors. Taking all these advantages 
into account, N. crassa possesses great potential to be 
further developed into an industrial production host for 
heterologous proteins.
While the further optimization will involve obvious 
steps, such as the introduction of a protease cleavage 
site between carrier and product or the development of 
a fed-batch process, also more general questions need to 
be addressed. These include: Why are heterologous pro-
teins not produced and secreted in similar amounts to 
endogenous proteins? How does codon usage influence 
productivity? What are the metabolic limitations for the 
expression of heterologous proteins? In addition, robust 
and reliable analytics for a product quantification and 
purification scheme need to be implemented.
Conclusions
This study describes the successful engineering of the 
eukaryotic model organism N.  crassa into a production 
host for heterologous proteins. Key steps included the 
development of a protease deficient strain, the use of a 
suited promoter system as well as bioprocess optimiza-
tion including identification of an optimal pH value and 
adjustment of the media composition. Only the combina-
tion of genetic manipulation and bioprocess optimization 
allowed the fast and efficient development of a produc-
tion system for antibody fragments with first yields of 




Most vectors were constructed by using yeast recombi-
nation cloning (YRC), as previously described [11]. After 
the assembly, a PCR was performed using the outermost 
primers in order to amplify the desired construct. The 
antibody fragment gene ht186-d11 was synthesized by 
GeneArt™ (Thermo Fisher Scientific, Germany) including 
codon optimization for the expression in N. crassa. The 
gene was amplified by PCR and subcloned into respective 
plasmids. Detailed lists of used and constructed plasmids 
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as well as the primers used are provided in Additional 
file 1: Tables S2, S3 and S4.
Construction of Pccg1nr
The novel promoter Pccg1nr contains two short deletions 
compared to the original ccg-1 promoter: CRE (Cyclic 
AMP Response, GTGACGTCAC) and NRS (Neurospora 
Repressor Site, TTGCTAGCAA) [56]. As a first step, two 
PCRs were performed creating DNA strands contain-
ing the CRE (primers 920 and 921) or NRS deletion (923 
and 925) with the ccg-1 containing plasmid pMF272 as a 
template. In a second step, yeast recombinational cloning 
[11] was applied to combine and integrate these two PCR 
products into the vector pRS426. The deletions were con-
firmed by sequencing and the ccg1nr promoter was ampli-
fied for further cloning with the primers 920 and 925.
Neurospora crassa strain construction
Strains used in this study are listed in Additional file  1: 
Table S5. For the construction of strains via transfor-
mation, recipient strains with respective deletions and 
mutations had to be generated. When combining multi-
ple deletions, crosses were performed in multiple steps 
on Westergaard’s medium [71]. Mating types were deter-
mined by crossing with the N.  crassa wild-types FGSC 
#2489 and FGSC #988. Strains with single gene dele-
tions were obtained from the Neurospora gene knock-
out library [11]. When combining multiple deletions 
based on the hph cassette, correct strains were identified 
by PCR analysis using genomic DNA as a template (for 
primers see Additional file 1: Table S4). Presence of the 
exo-1 mutation was determined by a plate assay based 
on starch degradation. Spores of the respective strain 
were spotted on solid Vogel’s medium containing sorbose 
(20  g/L) and starch (5  g/L) and incubated for 2–3  days 
at 30  °C. The agar was then dyed with Lugol’s solution 
(20 g/L potassium iodide and 10 g/L iodine). Strains car-
rying the exo-1 mutation developed a clear halo around 
the spots due to increased starch degradation.
After the construction of recipient strains, transforma-
tion of macroconidia with respective plasmids and sub-
sequent screening with PCR for homologous integration 
and single spore isolation was performed as previously 
described [72].
Cultivations in shake flasks
Most cultivations in liquid medium were performed 
in 250  mL shake flasks with or without baffles con-
taining 100  mL Vogel’s minimal medium with vary-
ing carbon sources. The concentration of the carbon 
sources was 10 g/L in shake flasks, if not indicated oth-
erwise. Standard Vogel’s minimal medium contained 
2.5  g/L sodium citrate  ×  2H2O, 5  g/L  KH2PO4, 2  g/L 
 NH4NO3, 0.2  g/L  MgSO4  ×  7H2O, 0.1  CaCl2  ×  2H2O 
as well as trace elements [73]. To obtain conidia, pro-
duction strains were grown on solid Vogel’s medium for 
7  days in slants or Erlenmeyer flasks. Spores were then 
harvested and washed three times in deionized water. 
Cultures were inoculated with a final concentration of 
5 × 105 − 1 × 106 spores/mL and incubated at 30 °C and 
100 rpm on a rotary shaker (Multitron, Infors HT, Swit-
zerland) or as indicated. Cultures were filter harvested on 
a Miracloth filter pad (Merck Millipore, USA). The myce-
lium was rinsed twice with deionized water and either 
dried at 80 °C for at least 48 h for dry biomass determina-
tion or frozen in liquid nitrogen for further analyses.
Bioreactor cultivations
For the process development, the DASGIP parallel bio-
reactor system (Eppendorf, Germany) was employed. 
Cultivations were carried out in four glass bioreactors 
(SR0700ODLS) including the corresponding gas analyzer 
and the control software. Cultures were inoculated to a 
final concentration of 1 × 106 spores/mL. Cultures were 
grown in Vogel’s minimal medium, Bird medium or com-
plex medium at 30  °C in a working volume of 800  mL. 
Optimized Bird medium contained 32.5 mM  (NH4)2SO4 
instead of  NH4Cl in addition to 20 g/L maltose, 4.85 g/L 
MES, 1.74 g/L  K2HPO4, 0.174 g/L  K2SO4, 0.058 g/L NaCl, 
0.203  g/L  MgCl2  ×  6H2O, 0.074  g/L  CaCl2  ×  2H2O as 
well as trace elements [51]. Complex medium was com-
posed of 10  g/L yeast extract, 10  g/L tryptone from 
casein, 5 g/L malt extract, 4.9 g/L MES and 17 g/L malt-
ose. The aeration was carried out with pressured air and 
was set to 0.5 vvm. The dissolved oxygen level was main-
tained at a minimum of 20% by controlling of the stirrer 
speed with an initial setting of 100 rpm. Used impellers 
were either two Rushton turbines or pitched blade impel-
lers. The pH was regulated by the addition of 12.5% (v/v) 
ammonia or 2  M sodium hydroxide (in experiments, in 
which the influence of the nitrogen concentration was 
analyzed). If necessary, antifoam agent (Schill + Seilacher 
“Struktol” GmbH, Germany) was added manually. Dry 
biomass weight was determined as described above.
Large scale cultivations were carried out in Biostat C 
stainless steel reactors (Sartorius, Germany). N.  crassa 
was cultivated in a working volume of 9.0 L with aeration 
and pH regulation comparable to the laboratory scale. 
Used impellers were three Rushton turbines and the cul-
tivation was controlled by UBICON software (ESD Elec-
tronic System Design, Germany).
Analysis of protein production
To determine the protein production, the biomass asso-
ciated fraction and the culture supernatant were ana-
lyzed. After cultivation was completed, the biomass was 
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filter harvested (Miracloth filter) and frozen in liquid 
nitrogen. Protein extraction and sodium dodecylsul-
phate-polyacrylamide gel electrophoresis (SDS-PAGE) 
were performed as described previously [74]. Proteins 
from the culture supernatant were precipitated by add-
ing 0.4 g  (NH4)2SO4 per mL of supernatant and incubated 
for 30  min at 4  °C. Precipitated proteins were pelleted 
(30 min, 20,000×g, 4  °C) and resuspended in 1/30 of the 
previous culture volume. Protein extracts and precipitated 
proteins were analyzed by SDS-PAGE including Coomas-
sie Brilliant Blue staining and Western blot analysis. Of 
crude protein extracts, approximately 50–100  µg of pro-
tein were loaded onto the gels, for precipitated proteins 
15  µL were loaded. After Western blotting, membranes 
were blocked with 2% (w/v) milk powder in PBS with 0.1% 
(v/v) Tween 20 (MPBS-T). The myc-tag was detected by 
anti c-myc antibody (clone 9E10, 1:5000, Sigma-Aldrich, 
USA), the his-tag with a 6×His epitope tag antibody (clone 
HIS.H8, 1:2000 in blocking buffer, Thermo Scientific, 
USA). Depending on the favored detection sensitivity, the 
NBT/BCIP system (Nitro blue tetrazolium chloride and 
5-Bromo-4-chloro-3-indolyl phosphate, insensitive) or the 
ECL (electrochemiluminescence, sensitive) was applied.
For the NBT/BCIP system, an anti-mouse IgG (Fc 
specific) alkaline phosphatase antibody (1:200,000 
in blocking buffer, Sigma-Aldrich, USA,) was used 
as the secondary antibody. Respective protein bands 
were stained with substrate buffer (0.03% (w/v) NBT, 
0.015% (w/v) BCIP, 100  mM Tris HCl, 0.5  mM  MgCl2, 
pH adjusted to 9.5). When the ECL system was applied 
the secondary antibody was F(ab’)2-goat anti-mouse 
IgG (H +  L), HRP conjugate (1:4000 in blocking buffer, 
Thermo Scientific, USA). The super signal west pico 
chemiluminescent substrate (Thermo Scientific, USA) 
was used for signal detection. Exposure times varied 
between 1 s and 15 min as stated in the figure captions.
Biochemical analyses
To determine the concentration of maltose and other 
reducing sugars, a colorimetric assay was performed 
based on Bernfeld [75]. For the reagents, 12 g of sodium 
potassium tartrate tetrahydrate were dissolved in 8  mL 
2  M NaOH. In parallel, a 96  mM 3,5-dinitrosalicylic 
acid solution was prepared in 20  mL of purified water. 
For the final color reagent solution, both solutions were 
slowly added to 12  mL of deionized water. All solu-
tions were prepared at 60  °C. The solution was stored 
in a dark environment. The concentration of reducing 
sugars was determined by adding 200  µL of the sample 
to 100  µL of the color reagent solution and heating to 
100  °C for 15  min. After cooling to room temperature, 
900  µL of deionized water were added and the absorp-
tion at a wavelength of 540  nm was measured. Final 
concentrations were calculated by comparing the values 
to a standard calibration.
The ammonium concentration was determined by 
using a commercial kit based on a UV method (R-Biop-
harm, Germany). The measurement was conducted 
according to the manufacturer.
Protease assay
As substrates for the protease activity assays, differ-
ent scFv including HT186-D11 were produced in E. coli 
using the expression vector pOPE101-XP. Production, 
isolation and purification of the scFv was performed as 
previously described [76]. The protease assay was con-
ducted by incubating filtrated supernatants (Miracloth 
filter) with 1 µg of purified HT186-D11 followed by SDS-
PAGE analysis. Missing bands of the scFv at 30 kD indi-
cated protease activity specific for the given scFv. For the 
comparison of protease activity between different sam-
ples, the intensities of the respective protein bands were 
determined with the image processing software ImageJ 
(https://imagej.nih.gov/ij/) and ratios were calculated in 
respect to an undigested scFv.
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